STAL

Share Price

₹00.00 0.00 (0.00%)

24 Nov, 2024 08:15

SIP TrendupStart SIP in STAL

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0
SIP Lightning

Smart Investing Starts Here Start SIP with for Steady Growth!

Invest Now

Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Financials

Technicals

What's your outlook on ?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Astal Laboratories Ltd has an operating revenue of Rs. 46.97 Cr. on a trailing 12-month basis. An annual revenue growth of 555% is outstanding, Pre-tax margin of 5% is okay, ROE of 3% is fair but needs improvement. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 135 indicates it belongs to a poor industry group of Real Estate Dvlpmt/Ops and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

F&O

Shareholding Pattern

19.93%
73.42%
6.65%

About

  • NSE Symbol
  • STAL
  • BSE Symbol
  • ISIN

Similar Stocks to

FAQs

share price is ₹00 As on 24 November, 2024 | 08:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23